Lilly reports tirzepatide trial results for obesity and pre-diabetes
Obesity Remedies

Lilly reports tirzepatide trial results for obesity and pre-diabetes

At the 15mg dose, participants showed a sustained average weight loss of 22.9% during the three-year treatment. Credit: SB Arts Media / Shutterstock. Eli Lilly has reported comprehensive outcomes from the SURMOUNT-1 study of tirzepatide (Zepbound and Mounjaro) for treating pre-diabetic and obese individuals. Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy […]

Welcome to Herbology News!

At Herbology News, we’re dedicated to empowering you with knowledge and resources to help you lead a healthier life naturally. 

Get Latest Updates and big deals

    Our expertise, as well as our passion for web design, sets us apart from other agencies.

    Herbologynews @2024. All Rights Reserved.